TNF and cancer: In addition, therapeutic antibodies targeting growth factors and their receptors such as epidermal growth factor receptor, insulin-like growth factor 1 receptor, tumor necrosis factor (TNF)-related apoptosis-inducing ligand receptors, and receptor activator nuclear factor-κB ligand (RANKL) have also been exploited for cancer treatment (11).